Available genetic information from extensive DNA analysis was barely being applied in the everyday healthcare process for individualised pharmacogenetic advice, but this valuable information is now available via the DNAmedicatiepas. The pass is an easy way for patients, physicians and pharmacists to verify whether the genetic profile of the individual patient is being taken into account. The pass is intended to reduce side eff ects and speed up the process of finding the right drug and dosage. The DNAmedicatiepas connects personal genetic information, based on whole exome sequencing (WES), with current Dutch medication recommendations. The personal pass has a QR code that contains the relevant genetic variants of the patient. The pharmacist or physician scan the pass to see whether the prescription needs to be adjusted based on the genetic profile.
